A detailed history of Darwin Advisors, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Darwin Advisors, LLC holds 45 shares of CVM stock, worth $16. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Holding current value
$16
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.05 - $1.5 $47 - $67
45 New
45 $0
Q2 2020

Aug 06, 2020

SELL
$9.75 - $17.6 $20,367 - $36,766
-2,089 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$7.54 - $17.05 $15,751 - $35,617
2,089 New
2,089 $24,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $16M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.